BG
Bunge Global SA
NYSE · Consumer Defensive · Agricultural Farm Products · US
$103.11
−2.85%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 91.8B | 70.3B | 53.1B | 59.5B | 67.2B |
| Cost of Revenue | 87.3B | 66.9B | 49.7B | 54.7B | 63.5B |
| Gross Profit | 4.5B | 3.4B | 3.4B | 4.8B | 3.7B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 2.5B | 2.1B | 1.8B | 1.7B | 1.4B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 2.5B | 2.1B | 1.8B | 1.7B | 1.4B |
| Cost and Expenses | 89.8B | 69.0B | 51.5B | 56.4B | 64.9B |
| Operating Income (EBIT) | 2.1B | 1.3B | 1.6B | 3.1B | 2.3B |
| Non-Operating | |||||
| Interest Income | 185.0M | 202.0M | 163.0M | 148.0M | 71.0M |
| Interest Expense | 796.0M | 628.0M | 471.0M | 516.0M | 403.0M |
| Net Interest Income | (611.0M) | (426.0M) | (308.0M) | (368.0M) | (332.0M) |
| Other Non-Op Income/Expense | (709.0M) | (162.0M) | (93.0M) | (79.0M) | (315.0M) |
| Non-Operating Income (excl Interest) | (87.0M) | (466.0M) | (378.0M) | (437.0M) | (88.0M) |
| EBT (Pre-Tax Income) | 1.4B | 1.1B | 1.5B | 3.1B | 2.0B |
| Income Tax Expense | 306.0M | 288.0M | 336.0M | 714.0M | 388.0M |
| Bottom Line | |||||
| Net Income | 1.0B | 816.0M | 1.1B | 2.2B | 1.6B |
| Earnings from Cont. Ops | 1.1B | 846.0M | 1.2B | 2.3B | 1.6B |
| Earnings from Discont. Ops | (3.0M) | (3.0M) | — | — | — |
| Bottom Line Net Income | 1.0B | 816.0M | 1.1B | 2.2B | 1.6B |
| Per Share | |||||
| Basic EPS | $5.19 | $4.95 | $8.09 | $15.07 | $10.52 |
| Diluted EPS | $5.16 | $4.91 | $7.99 | $14.87 | $10.51 |
| Revenue Per Share | $474.20 | $426.13 | $377.89 | $400.12 | $439.42 |
| Shares | |||||
| Basic Shares Outstanding | 193.6M | 165.0M | 140.5M | 148.8M | 153.0M |
| Diluted Shares Outstanding | 195.3M | 166.5M | 142.2M | 150.8M | 153.0M |
| Profitability Metrics | |||||
| EBITDA | 3.1B | 2.5B | 2.5B | 4.0B | 2.8B |
| D&A | 961.0M | 703.0M | 468.0M | 451.0M | 408.0M |
| EBIT | 2.2B | 1.8B | 2.0B | 3.6B | 2.4B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026